C4 Therapeutics Inc
(CCCC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 73,114 | 89,659 | 126,590 | 60,971 | 44,881 |
| Marketable Securities | 190,984 | 168,533 | 127,091 | 155,598 | 222,404 |
| Receivables | 1,167 | 13,599 | 11,799 | 500 | 1,028 |
| TOTAL | $276,044 | $279,592 | $271,189 | $223,686 | $274,387 |
| Non-Current Assets | |||||
| PPE Net | 6,571 | 6,756 | 7,132 | 7,290 | 7,572 |
| Investments And Advances | 31,637 | 40,975 | 28,008 | 29,857 | 19,415 |
| Other Non-Current Assets | 66,841 | 71,048 | 70,122 | 72,180 | 73,634 |
| TOTAL | $105,049 | $118,779 | $105,262 | $109,327 | $100,621 |
| Total Assets | $381,093 | $398,371 | $376,451 | $333,013 | $375,008 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 10,335 |
| Accounts payable and accrued liabilities | 913 | 1,630 | 1,446 | 1,276 | 2,247 |
| Accrued Expenses | 11,203 | 12,891 | 20,630 | 15,484 | 16,729 |
| TOTAL | $54,201 | $55,018 | $42,766 | $30,271 | $48,238 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 36,592 | 35,142 | 15,471 | 8,424 | 13,971 |
| Other Non-Current Liabilities | 62,924 | 64,365 | 65,757 | 67,095 | 68,416 |
| TOTAL | $79,834 | $85,071 | $87,571 | $86,718 | $93,063 |
| Total Liabilities | $134,035 | $140,089 | $130,337 | $116,989 | $141,301 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,338 | 68,806 | 68,601 | 49,281 | 49,191 |
| Common Shares | 7 | 7 | 6 | 5 | 5 |
| Retained earnings | -574,460 | -556,744 | -528,383 | -493,629 | -466,592 |
| Other shareholders' equity | -440 | -380 | -127 | -904 | -1,774 |
| TOTAL | $247,058 | $258,282 | $246,114 | $216,024 | $233,707 |
| Total Liabilities And Equity | $381,093 | $398,371 | $376,451 | $333,013 | $375,008 |